Abstract
This paper attempts to define a methodology for evaluating the potential benefits related to the adoption of innovative technologies such as Radio Frequency IDentification (RFID) and EPCglobal in some critical processes of a supply chain. The starting point of this work has been a quantitative and qualitative analysis carried out on a particular stakeholder of the pharmaceutical supply chain: the wholesaler. Some experimental measurements, derived by applying the Key Performance Indicator (KPI) method, are discussed. The case study presented allowed us to derive guidelines and indications for the development of a practical unified approach able to evaluate the RFID adoption from different perspectives and easily understandable also by company's top management.